Suchergebnisse - "Choudhary, Shalki"

PubPharm (8)

1

Hydantoin based dual inhibitors of ALR2 and PARP-1 : Design, synthesis, in-vitro and in-vivo evaluation

enthalten in: Bioorganic chemistry | 2022

von Kumar, M. | Kumar Singh, P. | Choudhary, S. | +1

2

Identification of missense SNP-mediated mutations in the regulatory sites of aldose reductase (ALR2) responsible for treatment failure in diabetic complications

enthalten in: Journal of molecular modeling | 2022

von Vyas, B. | Choudhary, S. | Verma, H. | +2

3

Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database : auto pharmacophore, ADMET prediction and molecular dynamics approach

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Choudhary, S. | Silakari, O.

4

Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D : an integrated machine learning and structure-based drug designing approach

enthalten in: Molecular diversity | 2021

von Mahajan, K. | Verma, H. | Choudhary, S. | +2

5

Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications

enthalten in: Future medicinal chemistry | 2020

von Kumar, M. | Choudhary, S. | Singh, P. | +1

6

Search for non-acidic ALR2 inhibitors : Evaluation of flavones as targeted agents for the management of diabetic complications

enthalten in: Bioorganic chemistry | 2020

von Vyas, B. | Choudhary, S. | Singh, P. | +5

7

hCES1 and hCES2 mediated activation of epalrestat-antioxidant mutual prodrugs : Unwinding the hydrolytic mechanism using in silico approaches

enthalten in: Journal of molecular graphics & modelling | 2019

von Choudhary, S. | Silakari, O.

8

Identification of 2-benzoxazolinone derivatives as lead against molecular targets of diabetic complications

enthalten in: Chemical biology & drug design | 2018

von Vyas, B. | Choudhary, S. | Singh, P. | +4

1
[1]